Diverse macrophages polarization in tumor microenvironment

Archives of Pharmacal Research

Volumn 39, Issue 11, 2016, Pages 1588-1596

  Rhee, Inmoo ^a  

^a Sejong University   (South Korea)

Author keywords

M1 macrophage; M2 macrophage; Macrophage polarization; Tumor associated macrophages (TAMs); Tumor microenvironment

Indexed keywords

CHEMOKINE; CYTOKINE; PROTEINASE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; PACLITAXEL;

ADAPTIVE IMMUNITY; ANGIOGENESIS; CANCER PROGNOSIS; CANCER THERAPY; CELL MIGRATION; CELL POLARITY; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; METASTASIS; NONHUMAN; PHENOTYPE; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; CELL MOTION; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; NEOPLASMS; PATHOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CELL MOVEMENT; CELL POLARITY; CYTOKINES; HUMANS; IMMUNITY, INNATE; MACROPHAGE ACTIVATION; MACROPHAGES; NEOPLASMS; PACLITAXEL; TUMOR MICROENVIRONMENT;

EID: 84983417800     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-016-0820-y     Document Type: Review

References (86)

1. Acosta-Iborra B, Elorza A, Olazabal IM, Martin-Cofreces NB, Martin-Puig S, Miro M, Calzada MJ, Aragones J, Sanchez-Madrid F, Landazuri MO (2009) Macrophage oxygen sensing modulates antigen presentation and phagocytic functions involving IFN-gamma production through the HIF-1 alpha transcription factor. J Immunol 182:3155–3164
2. Akifusa S, Kamio N, Shimazaki Y, Yamaguchi N, Nonaka K, Yamashita Y (2010) Involvement of the JAK-STAT pathway and SOCS3 in the regulation of adiponectin-generated reactive oxygen species in murine macrophage RAW 264 cells. J Cell Biochem 111:597–606
3. Allavena P, Chieppa M, Monti P, Piemonti L (2004) From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Crit Rev Immunol 24:179–192
4. Allavena P, Sica A, Solinas G, Porta C, Mantovani A (2008) The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol 66:1–9
5. Barros MH, Segges P, Vera-Lozada G, Hassan R, Niedobitek G (2015) Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival. PLoS One 10:e0124531
6. Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11:889–896
7. Cao W, Peters JH, Nieman D, Sharma M, Watson T, Yu J (2015) Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro. Br J Cancer 113:738–746
8. Cassetta L, Cassol E, Poli G (2011) Macrophage polarization in health and disease. Sci World J 11:2391–2402
9. Chang NC, Hung SI, Hwa KY, Kato I, Chen JE, Liu CH, Chang AC (2001) A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J Biol Chem 276:17497–17506
10. Chen WL, Chen YM, Chu HS, Lin CT, Chow LP, Chen CT, Hu FR (2014) Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization. PLoS One 9:e94205
11. Corbera-Bellalta M, Planas-Rigol E, Lozano E, Terrades-Garcia N, Alba MA, Prieto-Gonzalez S, Garcia-Martinez A, Albero R, Enjuanes A, Espigol-Frigole G, Hernández-Rodríguez J (2016) Blocking interferon gamma reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis. Ann Rheum Dis 75:1177–1186
12. Covarrubias A, Byles V, Horng T (2013) ROS sets the stage for macrophage differentiation. Cell Res 23:984–985
13. Deane S, Selmi C, Teuber SS, Gershwin ME (2010) Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol 153:109–120
14. Duluc D, Delneste Y, Tan F, Moles M-P, Grimaud L, Lenoir J, Preisser L, Anegon I, Catala L, Ifrah N, Descamps P, Gamelin E, Gascan H, Hebbar M, Jeannin P (2007) Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 110:4319–4330
15. Duluc D, Corvaisier M, Blanchard S, Catala L, Descamps P, Gamelin E, Ponsoda S, Delneste Y, Hebbar M, Jeannin P (2009) Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int J Cancer 125:367–373
16. Dumont P, Berton A, Nagy N, Sandras F, Tinton S, Demetter P, Mascart F, Allaoui A, Decaestecker C, Salmon I (2008) Expression of galectin-3 in the tumor immune response in colon cancer. Lab Investig J Tech Methods Pathol 88:896–906
17. El Husseiny NM, Fahmy HM, Mohamed WA, Amin HH (2012) Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus Egyptians. World J Hepatol 4:242–247
18. Essandoh K, Li Y, Huo J, Fan GC (2016) Mirna-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock 46:122–131
19. Fabriek BO, Dijkstra CD, van den Berg TK (2005) The macrophage scavenger receptor CD163. Immunobiology 210:153–160
20. Festuccia WT, Pouliot P, Bakan I, Sabatini DM, Laplante M (2014) Myeloid-specific Rictor deletion induces M1 macrophage polarization and potentiates in vivo pro-inflammatory response to lipopolysaccharide. PLoS One 9:e95432
21. Fukuda K, Kobayashi A, Watabe K (2012) The role of tumor-associated macrophage in tumor progression. Front Biosci 4:787–798
22. Gautam S, Banerjee M (2011) The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus. Mol Gen Metab 102:389–398
23. Germano G, Frapolli R, Belgiovine C, Anselmo A, Pesce S, Liguori M, Erba E, Uboldi S, Zucchetti M, Pasqualini F, Nebuloni M (2013) Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell 23:249–262
24. Gordon S (1995) The macrophage. BioEssays 17:977–986
25. Gordon S (1998) The role of the macrophage in immune regulation. Res Immunol 149:685–688
26. Gordon S, Pluddemann A (2013) Tissue macrophage heterogeneity: issues and prospects. Sem Immunopathol 35:533–540
27. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964
28. Gordon S, Pluddemann A, Martinez Estrada F (2014) Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immuno Rev 262:36–55
29. Graves DT, Jiang YL, Williamson MJ, Valente AJ (1989) Identification of monocyte chemotactic activity produced by malignant cells. Science 245:1490–1493
30. He J, Hu Y, Hu M, Li B (2015) Development of PD-1/PD-L1 pathway in tumor immune microenvironment and treatment for non-small cell lung cancer. Sci Rep 5:13110–13118
31. Hill AA, Reid Bolus W, Hasty AH (2014) A decade of progress in adipose tissue macrophage biology. Immunol Rev 262:134–152
32. Hiroshima Y, Maawy A, Hassanein MK, Menen R, Momiyama M, Murakami T, Miwa S, Yamamoto M, Uehara F, Yano S, Mori R (2014) The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. PLoS One 9:e103382
33. Hoesel B, Schmid JA (2013) The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 12:86–100
34. Hornell TM, Beresford GW, Bushey A, Boss JM, Mellins ED (2003) Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor. J Immunol 171:2374–2383
35. Hu X, Chakravarty SD, Ivashkiv LB (2008) Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev 226:41–56
36. Hume DA, MacDonald KP (2012) Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 119:1810–1820
37. Jones GE (2000) Cellular signaling in macrophage migration and chemotaxis. J Leukoc Biol 68:593–602
38. Joseph IB, Isaacs JT (1998) Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents. J Nat Cancer Inst 90:1648–1653
39. Joshi S, Singh AR, Zulcic M, Bao L, Messer K, Ideker T, Dutkowski J, Durden DL (2014) Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo. PLoS One 9:e95893
40. Kennedy BC, Showers CR, Anderson DE, Anderson L, Canoll P, Bruce JN, Anderson RC (2013) Tumor-associated macrophages in glioma: friend or foe? J Oncol 2013:486912
41. Lefevre L, Gales A, Olagnier D, Bernad J, Perez L, Burcelin R, Valentin A, Auwerx J, Pipy B, Coste A (2010) PPARgamma ligands switched high fat diet-induced macrophage M2b polarization toward M2a thereby improving intestinal Candida elimination. PLoS One 5:e12828
42. Li Y, Cai L, Wang H, Wu P, Gu W, Chen Y, Hao H, Tang K, Yi P, Liu M, Miao S (2011) Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2. Oncogene 30:3887–3899
43. Liddiard K, Rosas M, Davies LC, Jones SA, Taylor PR (2011) Macrophage heterogeneity and acute inflammation. Eur J Immunol 41:2503–2508
44. Lin L, Jin Y, Mars WM, Reeves WB, Hu K (2014) Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-kappaB pathways. Am J Pathol 184:2757–2767
45. Lu J, Cao Q, Zheng D, Sun Y, Wang C, Yu X, Wang Y, Lee VW, Zheng G, Tan TK, Wang X (2013) Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney Int 84:745–755
46. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555
47. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677–686
48. Mantovani A, Sica A, Locati M (2005) Macrophage polarization comes of age. Immunity 23:344–346
49. Mantovani A, Sica A, Allavena P, Garlanda C, Locati M (2009) Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Human Immunol 70:325–330
50. Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime reports 6: 13
51. Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453–461
52. Mazumder A, Bose M, Chakraborty A, Chakrabarti S, Bhattacharyya SN (2013) A transient reversal of miRNA-mediated repression controls macrophage activation. EMBO Rep 14:1008–1016
53. Melton DW, Lei X, Gelfond JA, Shireman PK (2016) Dynamic macrophage polarization-specific miRNA patterns reveal increased soluble VEGF receptor 1 by miR-125a-5p inhibition. Phys Genom 48:345–360
54. Montes VN, Turner MS, Subramanian S, Ding Y, Hayden-Ledbetter M, Slater S, Goodspeed L, Wang S, Omer M, Den Hartigh LJ, Averill MM (2013) T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice. PLoS One 8:e67709
55. Mullins DW, Burger CJ, Elgert KD (1999) Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. J Immunol 162:6811–6818
56. Murdoch C, Giannoudis A, Lewis CE (2004) Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104:2224–2234
57. Nelson MP, Christmann BS, Dunaway CW, Morris A, Steele C (2012) Experimental Pneumocystis lung infection promotes M2a alveolar macrophage-derived MMP12 production. Am J Physiol Lung Cell Mol Physiol 303:L469–L475
58. Niu M, Valdes S, Naguib YW, Hursting SD, Cui Z (2016) Tumor-associated macrophage-mediated targeted therapy of triple-negative breast cancer. Mol Pharm 13:1833–1842
59. Ohama H, Asai A, Ito I, Suzuki S, Kobayashi M, Higuchi K, Suzuki F (2015) M2b macrophage elimination and improved resistance of mice with chronic alcohol consumption to opportunistic infections. Am J Pathol 185:420–431
60. Ohlsson SM, Linge CP, Gullstrand B, Lood C, Johansson A, Ohlsson S, Lundqvist A, Bengtsson AA, Carlsson F, Hellmark T (2014) Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization. Clin Immunol 152:10–19
61. Outtz HH, Tattersall IW, Kofler NM, Steinbach N, Kitajewski J (2011) Notch1 controls macrophage recruitment and Notch signaling is activated at sites of endothelial cell anastomosis during retinal angiogenesis in mice. Blood 118:3436–3439
62. Park H, Ishihara D, Cox D (2011) Regulation of tyrosine phosphorylation in macrophage phagocytosis and chemotaxis. Arch Biochem Biophys 510:101–111
63. Perego RA, Bianchi C, Brando B, Urbano M, Del Monte U (1998) Increment of nonreceptor tyrosine kinase Arg RNA as evaluated by semiquantitative RT-PCR in granulocyte and macrophage-like differentiation of HL-60 cells. Exp Cell Res 245:146–154
64. Pixley FJ, Stanley ER (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14:628–638
65. Qian F, Deng J, Lee YG, Zhu J, Karpurapu M, Chung S, Zheng JN, Xiao L, Park GY, Christman JW (2015) The transcription factor PU.1 promotes alternative macrophage polarization and asthmatic airway inflammation. J Mol Cell Biol 7:557–567
66. Rai RK, Vishvakarma NK, Mohapatra TM, Singh SM (2012) Augmented macrophage differentiation and polarization of tumor-associated macrophages towards M1 subtype in listeria-administered tumor-bearing host. J Immunother 35:544–554
67. Rhee I, Davidson D, Souza CM, Vacher J, Veillette A (2013) Macrophage fusion is controlled by the cytoplasmic protein tyrosine phosphatase PTP-PEST/PTPN12. Mol Cell Biol 33:2458–2469
68. Robinson AP, White TM, Mason DW (1986) Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunol 57:239–247
69. Rőszer T (2015) Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediat Inflamm 2015:1–16
70. Ruffell B, Affara NI, Coussens LM (2012) Differential macrophage programming in the tumor microenvironment. Trends Immunol 33:119–126
71. Sanson M, Distel E, Fisher EA (2013) HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process. PLoS One 8:e74676
72. Shabo I, Olsson H, Elkarim R, Sun XF, Svanvik J (2014) macrophage infiltration in tumor stroma is related to tumor cell expression of CD163 in colorectal cancer. Cancer Microenviron Off J Int Cancer Microenviron Soc 7:61–69
73. Sironi M, Martinez FO, D’Ambrosio D, Gattorno M, Polentarutti N, Locati M, Gregorio A, Iellem A, Cassatella MA, Van Damme J, Sozzani S (2006) Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2). J Leukoc Biol 80:342–349
74. Solinas G, Germano G, Mantovani A, Allavena P (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86:1065–1073
75. Stock MK, Hammerich L, Do ON, Berres ML, Alsamman M, Heinrichs D, Nellen A, Trautwein C, Tacke F, Wasmuth HE (2013) Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression. Int J Clin Exp Pathol 6:678–685
76. Tashiro-Yamaji J, Kubota T, Yoshida R (2006) Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice. Gene 384:1–8
77. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S (2005) Macrophage receptors and immune recognition. Ann Rev Immunol 23:901–944
78. Thom JT, Walton SM, Torti N, Oxenius A (2014) Salivary gland resident APCs are Flt3L- and CCR2-independent macrophage-like cells incapable of cross-presentation. Eur J Immunol 44:706–714
79. Toh ML, Aeberli D, Lacey D, Yang Y, Santos LL, Clarkson M, Sharma L, Clyne C, Morand EF (2006) Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol 177:4818–4825
80. Tymoszuk P, Charoentong P, Hackl H, Spilka R, Muller-Holzner E, Trajanoski Z, Obrist P, Revillion F, Peyrat JP, Fiegl H, Doppler W (2014) High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer. BMC Cancer 14:257–269
81. van Kempen LC, de Visser KE, Coussens LM (2006) Inflammation, proteases and cancer. Eur J Cancer 42:728–734
82. Xu H, Zhu J, Smith S, Foldi J, Zhao B, Chung AY, Outtz H, Kitajewski J, Shi C, Weber S et al (2012) Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat Immunol 13:642–650
83. Xu Y, Romero R, Miller D, Kadam L, Mial TN, Plazyo O, Garcia-Flores V, Hassan SS, Xu Z, Tarca AL, Drewlo S (2016) An M1-like macrophage polarization in decidual tissue during spontaneous preterm labor that is attenuated by rosiglitazone treatment. J Immunol 196:2476–2491
84. Zhang W, Xu W, Xiong S (2010) Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J Immunol 184:6465–6478
85. Zhang J, Zhou Q, Yuan G, Dong M, Shi W (2015) Notch signaling regulates M2 type macrophage polarization during the development of proliferative vitreoretinopathy. Cell Immunol 298:77–82
86. Zhao XJ, Dong Q, Bindas J, Piganelli JD, Magill A, Reiser J, Kolls JK (2008) TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 181:3049–3056